US$ 26.42
ghk cu synergy with gh igf 1 Metabolic effects of IGF-1 and under pathological conditions. The GHK-CU "Peptide" 1 x 50mg
Description
No serious unexpected signals

During Phase I/II trials, patients reported adverse events similar to those of other vaccine candidates, including injection site pain, rash, headaches, muscle pain, fever, nausea and vomiting

2 [online], (2007)

Prevention of fistulas and stenosis Patients with IBD are often accompanied by intestinal fistula or intestinal cavity stenosis